Discovery of drug–omics associations in type 2 diabetes with generative deep-learning models

Medicin och livsvetenskap

• Deep Learning 100%
• Type 2 Diabetes Mellitus 54%
• Biomedical Technology 46%
• Polypharmacy 44%
• Atorvastatin 43%
• Simvastatin 43%
• Metformin 39%
• Gastrointestinal Microbiome 35%
• Hydroxymethylglutaryl-CoA Reductase Inhibitors 35%
• Computer Simulation 34%
• Pharmaceutical Preparations 30%
• Datasets 28%
• Therapeutics 5%

Kemiska föreningar

• Atorvastatin 53%
• Simvastatin 53%
• Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor 52%
• Metformin 51%
• Drug 38%
• Application 11%

Ingenjörs- och materialvetenskap

• Medical problems 79%
• Deep learning 64%
• Microorganisms 43%
• Statistical tests 42%